1AI 16.7% 0.7¢ algorae pharmaceuticals limited

Agree. Logically, if there was no potentially good data from the...

  1. 17,003 Posts.
    lightbulb Created with Sketch. 2410
    Agree. Logically, if there was no potentially good data from the first 2 groups it would make no difference to the outcome if the patients in the 120 unit cohort know or not... as I said earlier, any delay in the release suggests they found something in the 52 week data for the first 2 groups. And the results from patient number 1 tells its really possible. That Phase 1 data has been released as a concession to the shareholders as a clue.
    Last edited by whytee: 22/12/17
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $11.81M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $4.306K 615.1K

Buyers (Bids)

No. Vol. Price($)
15 6472967 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1765665 2
View Market Depth
Last trade - 12.43pm 26/09/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.